New urinary biomarkers show promise for bladder cancer detection and recurrence prediction. Learn more about this non-invasive diagnostic approach.
The Centers for Medicare & Medicaid Services has issued a permanent billing and reimbursement J-code, J9183, for the ...
ImmunityBio has successfully closed a $100 million financing arrangement aimed at accelerating the worldwide commercial launch of its bladder cancer treatment, ANKTIVA®. The market responded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results